CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 310 filers reported holding CRISPR THERAPEUTICS AG in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$5,091,351
-14.4%
112,169
+5.9%
0.00%
-20.0%
Q2 2023$5,948,707
+24.1%
105,9620.0%0.01%
+25.0%
Q1 2023$4,792,661
-12.6%
105,962
-21.4%
0.00%
-20.0%
Q4 2022$5,482,750
-43.2%
134,877
-8.7%
0.01%
-44.4%
Q3 2022$9,650,000
+21.9%
147,660
+13.3%
0.01%
+28.6%
Q2 2022$7,919,000
-12.2%
130,304
-9.3%
0.01%0.0%
Q1 2022$9,016,000
-11.1%
143,633
+7.4%
0.01%0.0%
Q4 2021$10,137,000
-34.5%
133,771
-3.3%
0.01%
-41.7%
Q3 2021$15,484,000
-30.3%
138,333
+0.8%
0.01%
-29.4%
Q2 2021$22,221,000
+23.4%
137,261
-7.1%
0.02%
+21.4%
Q1 2021$18,009,000
-16.9%
147,795
+4.4%
0.01%
-17.6%
Q4 2020$21,676,000
+111.7%
141,569
+15.7%
0.02%
+88.9%
Q3 2020$10,238,000
+34.2%
122,403
+17.9%
0.01%
+12.5%
Q2 2020$7,628,000
+493.2%
103,803
+242.3%
0.01%
+300.0%
Q1 2020$1,286,000
-27.0%
30,325
+4.8%
0.00%0.0%
Q4 2019$1,762,000
+149.9%
28,925
+68.2%
0.00%
+100.0%
Q3 2019$705,000
+7.6%
17,200
+23.7%
0.00%0.0%
Q2 2019$655,000
-74.0%
13,900
-80.3%
0.00%
-66.7%
Q1 2019$2,518,000
+21.5%
70,500
-2.8%
0.00%0.0%
Q4 2018$2,073,000
+91.8%
72,557
+197.6%
0.00%
+200.0%
Q3 2018$1,081,000
+3.3%
24,383
+37.0%
0.00%0.0%
Q2 2018$1,046,00017,7940.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders